Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions.
Mast cells, the major source of tissue heparin, line the vascular system. On stimulation, rat serosal mast cells release soluble heparin proteoglycans (HEP-PGs) of very high molecular weight (7500(K)). We compared the effects of HEP-PGs and standard heparins (average molecular weights, 15,000 and 5,000) on platelet-collagen interactions in vitro. In contrast with the standard heparins, HEP-PGs completely inhibited collagen-induced platelet aggregation and serotonin release in platelet-rich plasma. The inhibition caused by HEP-PGs depended on its macromolecular structure. In flowing blood, HEP-PGs also inhibited platelet deposition on a collagen-coated surface both at low and high shear rates. Although HEP-PGs did not block glycoprotein (GP) Ia/IIa-mediated platelet adhesion, they attenuated subsequent platelet activation and aggregation, as well as fibrinogen binding to platelets after collagen stimulation. HEP-PGs did not bind to platelets but bound tightly to von Willebrand factor (vWf) and enhanced its binding to collagen. Although platelet adhesion at high shear rate and vWf binding to GP Ib after ristocetin stimulation were not markedly affected, HEP-PGs reduced thrombin-induced aggregation and vWf binding to GP IIb/IIIa. These findings imply that activation of vascular mast cells with ensuing secretion of HEP-PGs may locally attenuate the thrombogenicity of matrix collagen by inhibiting its platelet-activating capacity.
Lassila
R
R
Wihuri Research Institute, Helsinki, Finland. riitta.lassila@wri.fimnet.fi
Lindstedt
K
K
Kovanen
P T
PT
D000818:Animals; D001777:Blood Coagulation; D001792:Blood Platelets / Q000378:metabolism*; D003094:Collagen / Q000378:metabolism*; D005089:Exocytosis; D005340:Fibrinogen / Q000378:metabolism; D006493:Heparin / Q000502:physiology*; D008274:Magnesium / Q000502:physiology; D008407:Mast Cells / Q000502:physiology*; D015539:Platelet Activation; D011509:Proteoglycans / Q000502:physiology*; D051381:Rats; D012212:Rheology; D012310:Ristocetin / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013917:Thrombin / Q000037:antagonists & inhibitors; D014841:von Willebrand Factor / Q000378:metabolism
D011509:Proteoglycans; D014841:von Willebrand Factor; D012310:Ristocetin; D012701:Serotonin; D005340:Fibrinogen; D006493:Heparin; D003094:Collagen; D013917:Thrombin; D008274:Magnesium